Realta Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Realta Investment Advisors's BMY Position: Q1 2025 in Review
Realta Investment Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 7,966 shares — an estimated $451K sold.
Realta Investment Advisors first reported a position in BMY in Q1 2019 and held it in 23 quarters. The position peaked at $1.59M in Q4 2019. 2,476 funds tracked by Wall St. Rank hold BMY as of Q1 2025.
- Realta Investment Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
- Realta Investment Advisors sold 7,966 Bristol-Myers Squibb shares in Q1 2025, an estimated $451K.
- Realta Investment Advisors first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 23 quarters.
- Realta Investment Advisors's Bristol-Myers Squibb position peaked at $1.59M in Q4 2019.
- 2,476 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.
Based on Realta Investment Advisors's 13F filing for Q1 2025, filed 1 May 2025.